Author:
Shi Congjie,Vilches Thomas N.,Li Ao,Wu Jianhong,Moghadas Seyed M.
Publisher
Springer International Publishing
Reference46 articles.
1. Alexander, M.E., Bowman, C.S., Feng, Z., Gardam, M., Moghadas, S.M., Röst, G., Wu, J., Yan, P.: Emergence of drug resistance: implications for antiviral control of pandemic influenza. Proc. R. Soc. B: Biol. Sci. 274(1619), 1675–1684 (2007)
2. Allué-Guardia, A., García, J.I., Torrelles, J.B.: Evolution of drug resistant mycobacterium tuberculosis strains and their adaptation to the human lung environment. Front. Microbiol. 12, 612675 (2021)
3. Arino, J., Bowman, C.S., Moghadas, S.M.: Antiviral resistance during pandemic influenza: implications for stockpiling and drug use. BMC Infect. Dis. 9(1), 1–12 (2009)
4. Center for Disease Control and Prevention: Covid-19 and antimicrobial resistance (2022). https://www.cdc.gov/drugresistance/covid19.html. Accessed 1 Oct 2022
5. Chadha, J., Khullar, L., Mittal, N.: Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic. Environ. Microbiol. 24(6), 2615–2629 (2022)